These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21311411)

  • 41. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
    Cao Q; Zhu Q; Shang Y; Gao M; Si J
    Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of introducing thioguanine nucleotide monitoring into an inflammatory bowel disease clinic.
    Smith M; Blaker P; Patel C; Marinaki A; Arenas M; Escuredo E; Anderson S; Irving P; Sanderson J
    Int J Clin Pract; 2013 Feb; 67(2):161-9. PubMed ID: 23253089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring of inosine monophosphate dehydrogenase activity in mononuclear cells of children with acute lymphoblastic leukemia: enzymological and clinical aspects.
    Brouwer C; Vermunt-de Koning DG; Trueworthy RC; Ter Riet PG; Duley JA; Trijbels FJ; Hoogerbrugge PM; Bökkerink JP; van Wering ER; De Abreu RA
    Pediatr Blood Cancer; 2006 Apr; 46(4):434-8. PubMed ID: 16333815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meta-analysis: Inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease.
    Van Dieren JM; Hansen BE; Kuipers EJ; Nieuwenhuis EE; Van der Woude CJ
    Aliment Pharmacol Ther; 2007 Sep; 26(5):643-52. PubMed ID: 17697198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
    Vethe NT; Bremer S; Bergan S
    Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of aminosalicylates on thiopurine S-methyltransferase activity: an ex vivo study in patients with inflammatory bowel disease.
    Xin H; Fischer C; Schwab M; Klotz U
    Aliment Pharmacol Ther; 2005 May; 21(9):1105-9. PubMed ID: 15854172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allopurinol enhances the activity of hypoxanthine-guanine phosphoribosyltransferase in inflammatory bowel disease patients during low-dose thiopurine therapy: preliminary data of an ongoing series.
    Seinen ML; de Boer NK; Smid K; van Asseldonk DP; Bouma G; van Bodegraven AA; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1085-90. PubMed ID: 22132961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Limited intra-individual variability in hypoxanthine-Guanine phosphoribosyl transferase, thiopurine S-methyl transferase, and xanthine oxidase activity in inflammatory bowel disease patients during 6-thioguanine therapy.
    van Asseldonk DP; de Boer NK; Smid K; Mulder CJ; van Bodegraven AA; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):284-90. PubMed ID: 20544508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene expression and thiopurine metabolite profiling in inflammatory bowel disease - novel clues to drug targets and disease mechanisms?
    Haglund S; Almer S; Peterson C; Söderman J
    PLoS One; 2013; 8(2):e56989. PubMed ID: 23437289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimizing thiopurine therapy: more weight to the metabolite argument.
    Gibson PR; Gearry RB
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1592-4. PubMed ID: 20880165
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
    De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
    Krynetski EY; Krynetskaia NF; Yanishevski Y; Evans WE
    Mol Pharmacol; 1995 Jun; 47(6):1141-7. PubMed ID: 7603453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugs.
    Sheffield LJ; Irving P; Gupta A; Byron K; Macrae FA; Phillimore H; Dronavalli M; Rose R; George P; Walmsley T; Dixon B; Poole S; Dooley M; Sparrow M
    Pharmacogenomics; 2009 Jul; 10(7):1091-9. PubMed ID: 19604082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thiopurine S-methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients.
    Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Syriopoulou VP; Goutas N; Vlachodimitropoulos D; Anagnou NP; Roma-Giannikou E
    J Clin Pharm Ther; 2010 Feb; 35(1):93-7. PubMed ID: 20175817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of thiopurine metabolite testing and thiopurine methyltransferase determination in pediatric IBD.
    Benkov K; Lu Y; Patel A; Rahhal R; Russell G; Teitelbaum J;
    J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):333-40. PubMed ID: 23287804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extended thiopurine metabolite assessment during 6-thioguanine therapy for immunomodulation in Crohn's disease.
    de Boer NK; Derijks LJ; Keizer-Garritsen JJ; Lambooy LH; Ruitenbeek W; Hooymans PM; van Bodegraven AA; de Jong DJ
    J Clin Pharmacol; 2007 Feb; 47(2):187-91. PubMed ID: 17244769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of mycophenolic acid on inosine monophosphate dehydrogenase I and II mRNA expression in white blood cells and various tissues in sheep.
    Dzidic A; Prgomet C; Mohr A; Meyer K; Bauer J; Meyer HH; Pfaffl MW
    J Vet Med A Physiol Pathol Clin Med; 2006 May; 53(4):163-9. PubMed ID: 16629948
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review article: thiopurines in inflammatory bowel disease.
    Derijks LJ; Gilissen LP; Hooymans PM; Hommes DW
    Aliment Pharmacol Ther; 2006 Sep; 24(5):715-29. PubMed ID: 16918876
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease.
    Moon W; Loftus EV
    Aliment Pharmacol Ther; 2016 Apr; 43(8):863-883. PubMed ID: 26876431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease.
    Wong DR; Coenen MJ; Derijks LJ; Vermeulen SH; van Marrewijk CJ; Klungel OH; Scheffer H; Franke B; Guchelaar HJ; de Jong DJ; Engels LG; Verbeek AL; Hooymans PM;
    Aliment Pharmacol Ther; 2017 Feb; 45(3):391-402. PubMed ID: 27943397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.